

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 9.04429139 |
| 2 | muscle filament sliding (GO:0030049) | 8.96117720 |
| 3 | actin-myosin filament sliding (GO:0033275) | 8.96117720 |
| 4 | cardiac myofibril assembly (GO:0055003) | 8.48457479 |
| 5 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 8.04223519 |
| 6 | myofibril assembly (GO:0030239) | 7.99080967 |
| 7 | actin-mediated cell contraction (GO:0070252) | 7.44294232 |
| 8 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.13381488 |
| 9 | regulation of skeletal muscle contraction (GO:0014819) | 7.05246177 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.82257229 |
| 11 | cardiac muscle contraction (GO:0060048) | 6.77668529 |
| 12 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.67427282 |
| 13 | tricarboxylic acid cycle (GO:0006099) | 6.37385389 |
| 14 | cardiac muscle cell development (GO:0055013) | 6.30054730 |
| 15 | plasma membrane repair (GO:0001778) | 6.18034203 |
| 16 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.14653483 |
| 17 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.11393104 |
| 18 | striated muscle contraction (GO:0006941) | 5.97289511 |
| 19 | regulation of relaxation of muscle (GO:1901077) | 5.96294583 |
| 20 | actomyosin structure organization (GO:0031032) | 5.94350653 |
| 21 | cardiac cell development (GO:0055006) | 5.91290498 |
| 22 | regulation of actin filament-based movement (GO:1903115) | 5.79509959 |
| 23 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.72481605 |
| 24 | actin filament-based movement (GO:0030048) | 5.56145098 |
| 25 | carnitine shuttle (GO:0006853) | 5.55908300 |
| 26 | cardiac muscle hypertrophy (GO:0003300) | 5.53532744 |
| 27 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.52120833 |
| 28 | regulation of sarcomere organization (GO:0060297) | 5.46404851 |
| 29 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.39782079 |
| 30 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.38513449 |
| 31 | heart contraction (GO:0060047) | 5.34172390 |
| 32 | heart process (GO:0003015) | 5.34172390 |
| 33 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.33054481 |
| 34 | striated muscle hypertrophy (GO:0014897) | 5.31854493 |
| 35 | adult heart development (GO:0007512) | 5.26532020 |
| 36 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.25512658 |
| 37 | regulation of cell communication by electrical coupling (GO:0010649) | 5.24420813 |
| 38 | muscle tissue morphogenesis (GO:0060415) | 5.21499192 |
| 39 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.14925299 |
| 40 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.01121001 |
| 41 | regulation of striated muscle contraction (GO:0006942) | 4.95942467 |
| 42 | skeletal muscle contraction (GO:0003009) | 4.94554446 |
| 43 | heart trabecula formation (GO:0060347) | 4.92368760 |
| 44 | fatty acid transmembrane transport (GO:1902001) | 4.83078769 |
| 45 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.78761292 |
| 46 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.78586618 |
| 47 | muscle hypertrophy (GO:0014896) | 4.71075833 |
| 48 | regulation of coenzyme metabolic process (GO:0051196) | 4.61923261 |
| 49 | regulation of cofactor metabolic process (GO:0051193) | 4.61923261 |
| 50 | regulation of membrane repolarization (GO:0060306) | 4.53490571 |
| 51 | cardiac chamber formation (GO:0003207) | 4.40867509 |
| 52 | regulation of the force of heart contraction (GO:0002026) | 4.37180464 |
| 53 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.35995054 |
| 54 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.31129340 |
| 55 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.16287259 |
| 56 | cell communication involved in cardiac conduction (GO:0086065) | 4.15775299 |
| 57 | carnitine transmembrane transport (GO:1902603) | 4.10954559 |
| 58 | muscle contraction (GO:0006936) | 4.07898850 |
| 59 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.04445979 |
| 60 | muscle hypertrophy in response to stress (GO:0003299) | 4.04445979 |
| 61 | cardiac muscle adaptation (GO:0014887) | 4.04445979 |
| 62 | skeletal muscle fiber development (GO:0048741) | 4.03415547 |
| 63 | oxidative phosphorylation (GO:0006119) | 4.02963261 |
| 64 | striated muscle cell development (GO:0055002) | 3.99688001 |
| 65 | cardiac ventricle formation (GO:0003211) | 3.98720288 |
| 66 | creatine metabolic process (GO:0006600) | 3.97259097 |
| 67 | ATP synthesis coupled proton transport (GO:0015986) | 3.96177947 |
| 68 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.96177947 |
| 69 | response to inactivity (GO:0014854) | 3.92418873 |
| 70 | skeletal muscle adaptation (GO:0043501) | 3.88371820 |
| 71 | negative regulation of protein localization to cell surface (GO:2000009) | 3.87922512 |
| 72 | striated muscle adaptation (GO:0014888) | 3.86954537 |
| 73 | myotube cell development (GO:0014904) | 3.85791888 |
| 74 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.80242512 |
| 75 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.79800258 |
| 76 | muscle system process (GO:0003012) | 3.78832475 |
| 77 | cardiac muscle cell action potential (GO:0086001) | 3.77444190 |
| 78 | negative regulation of potassium ion transport (GO:0043267) | 3.77116333 |
| 79 | regulation of cardiac muscle contraction (GO:0055117) | 3.74800294 |
| 80 | carnitine transport (GO:0015879) | 3.74390347 |
| 81 | amino-acid betaine transport (GO:0015838) | 3.74390347 |
| 82 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.73523045 |
| 83 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.73341386 |
| 84 | regulation of sulfur metabolic process (GO:0042762) | 3.72968620 |
| 85 | skeletal muscle tissue development (GO:0007519) | 3.72610861 |
| 86 | regulation of heart rate (GO:0002027) | 3.72097750 |
| 87 | cell communication by electrical coupling (GO:0010644) | 3.71720962 |
| 88 | respiratory electron transport chain (GO:0022904) | 3.71624003 |
| 89 | regulation of ATPase activity (GO:0043462) | 3.70899287 |
| 90 | regulation of ATP catabolic process (GO:1903289) | 3.70899287 |
| 91 | muscle cell fate commitment (GO:0042693) | 3.70062253 |
| 92 | regulation of cardioblast differentiation (GO:0051890) | 3.66786057 |
| 93 | regulation of heart contraction (GO:0008016) | 3.66739664 |
| 94 | 2-oxoglutarate metabolic process (GO:0006103) | 3.63644349 |
| 95 | muscle cell cellular homeostasis (GO:0046716) | 3.63439184 |
| 96 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.63074429 |
| 97 | regulation of muscle system process (GO:0090257) | 3.62602119 |
| 98 | NADH metabolic process (GO:0006734) | 3.61276562 |
| 99 | relaxation of muscle (GO:0090075) | 3.60739494 |
| 100 | electron transport chain (GO:0022900) | 3.60320483 |
| 101 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.56925343 |
| 102 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.55111823 |
| 103 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.55111823 |
| 104 | relaxation of cardiac muscle (GO:0055119) | 3.52595541 |
| 105 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.50991928 |
| 106 | ventricular cardiac muscle cell development (GO:0055015) | 3.49026302 |
| 107 | glycogen catabolic process (GO:0005980) | 3.43473979 |
| 108 | muscle cell development (GO:0055001) | 3.42832736 |
| 109 | regulation of muscle contraction (GO:0006937) | 3.42591064 |
| 110 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.42286184 |
| 111 | glycogen biosynthetic process (GO:0005978) | 3.40852844 |
| 112 | glucan biosynthetic process (GO:0009250) | 3.40852844 |
| 113 | muscle fiber development (GO:0048747) | 3.39144015 |
| 114 | response to muscle activity (GO:0014850) | 3.39041514 |
| 115 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.38777840 |
| 116 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.38777840 |
| 117 | muscle adaptation (GO:0043500) | 3.38651941 |
| 118 | response to caffeine (GO:0031000) | 3.36831589 |
| 119 | positive regulation of cation channel activity (GO:2001259) | 3.34556267 |
| 120 | glucan catabolic process (GO:0009251) | 3.31757316 |
| 121 | muscle organ development (GO:0007517) | 3.30564721 |
| 122 | muscle structure development (GO:0061061) | 3.29600087 |
| 123 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.26600696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.94238738 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 5.18548989 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.74450924 |
| 4 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.25292787 |
| 5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.25292787 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.13254628 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.86303982 |
| 8 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.68411121 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.66697082 |
| 10 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.60960901 |
| 11 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.11172426 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.98802869 |
| 13 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.70144366 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.63360044 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.29809009 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.23545876 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.23081837 |
| 18 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.16745311 |
| 19 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.05789206 |
| 20 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 2.04779902 |
| 21 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.96202662 |
| 22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.91167242 |
| 23 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.75961966 |
| 24 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.75766036 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.74313028 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.70757394 |
| 27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.53977402 |
| 28 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.51356076 |
| 29 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.50515092 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49107164 |
| 31 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.46423499 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.45499647 |
| 33 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.44761283 |
| 34 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.42069469 |
| 35 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.37181171 |
| 36 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.34185632 |
| 37 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.32561374 |
| 38 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.32449187 |
| 39 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.29527674 |
| 40 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.28495252 |
| 41 | VDR_22108803_ChIP-Seq_LS180_Human | 1.26077934 |
| 42 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.25100884 |
| 43 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.24436107 |
| 44 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.23512523 |
| 45 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.20425090 |
| 46 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.17365031 |
| 47 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.17214971 |
| 48 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15824993 |
| 49 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12616464 |
| 50 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.12583055 |
| 51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12114699 |
| 52 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12104513 |
| 53 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12008366 |
| 54 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.10670009 |
| 55 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.10670009 |
| 56 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.09964681 |
| 57 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.09279856 |
| 58 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.08542932 |
| 59 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07297690 |
| 60 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07196473 |
| 61 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.06112963 |
| 62 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05545604 |
| 63 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.03610701 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.02464495 |
| 65 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.02289830 |
| 66 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.01564314 |
| 67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.01058018 |
| 68 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00947158 |
| 69 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.98999590 |
| 70 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98535867 |
| 71 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98535867 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97517959 |
| 73 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.97303381 |
| 74 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95227692 |
| 75 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95063572 |
| 76 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94419552 |
| 77 | CJUN_26792858_Chip-Seq_BT549_Human | 0.94107763 |
| 78 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.93993242 |
| 79 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.93924615 |
| 80 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.93803188 |
| 81 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.93779274 |
| 82 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.92988693 |
| 83 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.92634933 |
| 84 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.92296795 |
| 85 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.91937864 |
| 86 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91242796 |
| 87 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.90810884 |
| 88 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.90356213 |
| 89 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90028083 |
| 90 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.88245798 |
| 91 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87789575 |
| 92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.87169821 |
| 93 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.86229911 |
| 94 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.86089459 |
| 95 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.86068696 |
| 96 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.85758883 |
| 97 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.85575865 |
| 98 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.85426710 |
| 99 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.85167340 |
| 100 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.85025437 |
| 101 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84340533 |
| 102 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.83717522 |
| 103 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83683501 |
| 104 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.83264722 |
| 105 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.82946259 |
| 106 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.82526008 |
| 107 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.81789187 |
| 108 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.81511072 |
| 109 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.81425004 |
| 110 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.80888006 |
| 111 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.80832914 |
| 112 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.80473709 |
| 113 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.78954112 |
| 114 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.78884642 |
| 115 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.78860963 |
| 116 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.78288745 |
| 117 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.78255724 |
| 118 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.78013765 |
| 119 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.77404063 |
| 120 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77372621 |
| 121 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.77366742 |
| 122 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.76769966 |
| 123 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.76338935 |
| 124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.76318446 |
| 125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.74926903 |
| 126 | P68_20966046_ChIP-Seq_HELA_Human | 0.74696003 |
| 127 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.74213024 |
| 128 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.73855009 |
| 129 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73115159 |
| 130 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.73052915 |
| 131 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.72843820 |
| 132 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.72722141 |
| 133 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.72385473 |
| 134 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.72134886 |
| 135 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.71459692 |
| 136 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.71366255 |
| 137 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.70125047 |
| 138 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.69281643 |
| 139 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.68660116 |
| 140 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.67570401 |
| 141 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.67221458 |
| 142 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.66975352 |
| 143 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.66917316 |
| 144 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.65988448 |
| 145 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65786279 |
| 146 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.64865500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.01773991 |
| 2 | MP0004084_abnormal_cardiac_muscle | 5.58097711 |
| 3 | MP0003646_muscle_fatigue | 5.50822768 |
| 4 | MP0000751_myopathy | 5.18960906 |
| 5 | MP0000749_muscle_degeneration | 4.74955843 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.61944241 |
| 7 | MP0004215_abnormal_myocardial_fiber | 4.33850450 |
| 8 | MP0005330_cardiomyopathy | 3.81155701 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 3.64981161 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.35449408 |
| 11 | MP0002972_abnormal_cardiac_muscle | 3.08152020 |
| 12 | MP0002106_abnormal_muscle_physiology | 3.02513166 |
| 13 | MP0005620_abnormal_muscle_contractility | 3.01191414 |
| 14 | MP0000750_abnormal_muscle_regeneration | 2.89829336 |
| 15 | MP0008775_abnormal_heart_ventricle | 2.77624614 |
| 16 | MP0004130_abnormal_muscle_cell | 2.68229451 |
| 17 | MP0003137_abnormal_impulse_conducting | 2.67208217 |
| 18 | MP0002269_muscular_atrophy | 2.67092523 |
| 19 | MP0000747_muscle_weakness | 2.56453723 |
| 20 | * MP0010630_abnormal_cardiac_muscle | 2.50022197 |
| 21 | MP0001544_abnormal_cardiovascular_syste | 2.46218389 |
| 22 | MP0005385_cardiovascular_system_phenoty | 2.46218389 |
| 23 | MP0005369_muscle_phenotype | 2.44912333 |
| 24 | MP0000759_abnormal_skeletal_muscle | 2.38965187 |
| 25 | MP0004484_altered_response_of | 2.35174611 |
| 26 | MP0006138_congestive_heart_failure | 2.17971273 |
| 27 | MP0003828_pulmonary_edema | 2.05728896 |
| 28 | MP0003221_abnormal_cardiomyocyte_apopto | 2.05127762 |
| 29 | MP0004233_abnormal_muscle_weight | 2.01867352 |
| 30 | MP0004085_abnormal_heartbeat | 1.93525584 |
| 31 | MP0004510_myositis | 1.88558910 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 1.85269761 |
| 33 | MP0003950_abnormal_plasma_membrane | 1.66061512 |
| 34 | MP0002127_abnormal_cardiovascular_syste | 1.65252038 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.57063265 |
| 36 | MP0003567_abnormal_fetal_cardiomyocyte | 1.45421039 |
| 37 | MP0005666_abnormal_adipose_tissue | 1.29593638 |
| 38 | MP0006035_abnormal_mitochondrial_morpho | 1.13512181 |
| 39 | * MP0000266_abnormal_heart_morphology | 1.11915940 |
| 40 | MP0002234_abnormal_pharynx_morphology | 1.07325644 |
| 41 | MP0000733_abnormal_muscle_development | 1.07294715 |
| 42 | MP0002108_abnormal_muscle_morphology | 1.05797093 |
| 43 | MP0000343_altered_response_to | 1.04163484 |
| 44 | MP0001661_extended_life_span | 1.01885484 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.00603949 |
| 46 | MP0004185_abnormal_adipocyte_glucose | 1.00362012 |
| 47 | MP0005670_abnormal_white_adipose | 0.97679311 |
| 48 | MP0005451_abnormal_body_composition | 0.91764079 |
| 49 | MP0003279_aneurysm | 0.88941052 |
| 50 | MP0005266_abnormal_metabolism | 0.88469860 |
| 51 | MP0004270_analgesia | 0.87419321 |
| 52 | MP0005165_increased_susceptibility_to | 0.86702241 |
| 53 | MP0005375_adipose_tissue_phenotype | 0.85929239 |
| 54 | MP0010368_abnormal_lymphatic_system | 0.85818551 |
| 55 | MP0002128_abnormal_blood_circulation | 0.74363579 |
| 56 | MP0003705_abnormal_hypodermis_morpholog | 0.74226867 |
| 57 | MP0002822_catalepsy | 0.73122832 |
| 58 | MP0000230_abnormal_systemic_arterial | 0.72353306 |
| 59 | MP0003566_abnormal_cell_adhesion | 0.70905245 |
| 60 | MP0002971_abnormal_brown_adipose | 0.66977624 |
| 61 | MP0003045_fibrosis | 0.62395906 |
| 62 | MP0005623_abnormal_meninges_morphology | 0.58411624 |
| 63 | MP0004043_abnormal_pH_regulation | 0.54749908 |
| 64 | MP0000013_abnormal_adipose_tissue | 0.54532600 |
| 65 | MP0000767_abnormal_smooth_muscle | 0.54508354 |
| 66 | MP0004272_abnormal_basement_membrane | 0.53960550 |
| 67 | MP0001879_abnormal_lymphatic_vessel | 0.52185219 |
| 68 | MP0003941_abnormal_skin_development | 0.49721094 |
| 69 | MP0000003_abnormal_adipose_tissue | 0.47873971 |
| 70 | MP0002925_abnormal_cardiovascular_devel | 0.46821525 |
| 71 | MP0005319_abnormal_enzyme/_coenzyme | 0.46520874 |
| 72 | MP0004147_increased_porphyrin_level | 0.45549131 |
| 73 | MP0002078_abnormal_glucose_homeostasis | 0.44933963 |
| 74 | MP0009384_cardiac_valve_regurgitation | 0.43135850 |
| 75 | MP0005275_abnormal_skin_tensile | 0.41049658 |
| 76 | MP0009780_abnormal_chondrocyte_physiolo | 0.40727624 |
| 77 | MP0001784_abnormal_fluid_regulation | 0.38376787 |
| 78 | MP0005187_abnormal_penis_morphology | 0.37089963 |
| 79 | * MP0003984_embryonic_growth_retardation | 0.36765623 |
| 80 | MP0008961_abnormal_basal_metabolism | 0.36682526 |
| 81 | * MP0002088_abnormal_embryonic_growth/wei | 0.36676936 |
| 82 | MP0001614_abnormal_blood_vessel | 0.35768082 |
| 83 | MP0008438_abnormal_cutaneous_collagen | 0.34892181 |
| 84 | MP0008569_lethality_at_weaning | 0.33943367 |
| 85 | MP0003948_abnormal_gas_homeostasis | 0.32621589 |
| 86 | MP0002638_abnormal_pupillary_reflex | 0.32522928 |
| 87 | MP0002909_abnormal_adrenal_gland | 0.32413887 |
| 88 | MP0000372_irregular_coat_pigmentation | 0.28915232 |
| 89 | MP0009250_abnormal_appendicular_skeleto | 0.28323337 |
| 90 | MP0004134_abnormal_chest_morphology | 0.26503595 |
| 91 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.26461281 |
| 92 | MP0005334_abnormal_fat_pad | 0.26046967 |
| 93 | MP0005535_abnormal_body_temperature | 0.22580193 |
| 94 | MP0002249_abnormal_larynx_morphology | 0.22345357 |
| 95 | MP0002114_abnormal_axial_skeleton | 0.21305339 |
| 96 | MP0005595_abnormal_vascular_smooth | 0.21131345 |
| 97 | MP0001727_abnormal_embryo_implantation | 0.20890628 |
| 98 | MP0010030_abnormal_orbit_morphology | 0.20579682 |
| 99 | MP0005452_abnormal_adipose_tissue | 0.20332753 |
| 100 | MP0009672_abnormal_birth_weight | 0.20277903 |
| 101 | MP0000762_abnormal_tongue_morphology | 0.19241517 |
| 102 | MP0002896_abnormal_bone_mineralization | 0.19103362 |
| 103 | MP0005376_homeostasis/metabolism_phenot | 0.19081729 |
| 104 | MP0002118_abnormal_lipid_homeostasis | 0.19000913 |
| 105 | MP0003879_abnormal_hair_cell | 0.18263745 |
| 106 | MP0003195_calcinosis | 0.18192072 |
| 107 | MP0009115_abnormal_fat_cell | 0.17532823 |
| 108 | MP0004924_abnormal_behavior | 0.17484539 |
| 109 | MP0005386_behavior/neurological_phenoty | 0.17484539 |
| 110 | MP0001984_abnormal_olfaction | 0.17334197 |
| 111 | MP0005377_hearing/vestibular/ear_phenot | 0.17148410 |
| 112 | MP0003878_abnormal_ear_physiology | 0.17148410 |
| 113 | * MP0001672_abnormal_embryogenesis/_devel | 0.17042247 |
| 114 | * MP0005380_embryogenesis_phenotype | 0.17042247 |
| 115 | MP0005332_abnormal_amino_acid | 0.16756910 |
| 116 | MP0005083_abnormal_biliary_tract | 0.16633443 |
| 117 | MP0005085_abnormal_gallbladder_physiolo | 0.15690160 |
| 118 | MP0005503_abnormal_tendon_morphology | 0.15682447 |
| 119 | MP0003656_abnormal_erythrocyte_physiolo | 0.15498288 |
| 120 | MP0000249_abnormal_blood_vessel | 0.15408127 |
| 121 | MP0001958_emphysema | 0.15373258 |
| 122 | MP0000534_abnormal_ureter_morphology | 0.14877249 |
| 123 | MP0001943_abnormal_respiration | 0.14688600 |
| 124 | MP0001299_abnormal_eye_distance/ | 0.12855345 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.39996715 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 7.12536535 |
| 3 | Exercise-induced myalgia (HP:0003738) | 7.09418339 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 6.81143875 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.59048508 |
| 6 | Ventricular tachycardia (HP:0004756) | 5.99894814 |
| 7 | Muscle fiber splitting (HP:0003555) | 5.65883610 |
| 8 | Myoglobinuria (HP:0002913) | 5.39024549 |
| 9 | Abnormality of the calf musculature (HP:0001430) | 5.38915230 |
| 10 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.34034092 |
| 11 | Subaortic stenosis (HP:0001682) | 5.34034092 |
| 12 | Hyporeflexia of lower limbs (HP:0002600) | 5.21053117 |
| 13 | Atrial fibrillation (HP:0005110) | 5.16098575 |
| 14 | Muscle fiber inclusion bodies (HP:0100299) | 4.86627876 |
| 15 | Primary atrial arrhythmia (HP:0001692) | 4.81462801 |
| 16 | Lipoatrophy (HP:0100578) | 4.76559686 |
| 17 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.76384312 |
| 18 | Supraventricular tachycardia (HP:0004755) | 4.65068362 |
| 19 | EMG: myopathic abnormalities (HP:0003458) | 4.61122098 |
| 20 | Supraventricular arrhythmia (HP:0005115) | 4.55423592 |
| 21 | Type 1 muscle fiber predominance (HP:0003803) | 4.34096700 |
| 22 | Rhabdomyolysis (HP:0003201) | 4.32108384 |
| 23 | Right ventricular cardiomyopathy (HP:0011663) | 4.30049456 |
| 24 | Syncope (HP:0001279) | 4.17818708 |
| 25 | Nemaline bodies (HP:0003798) | 4.15367566 |
| 26 | Difficulty running (HP:0009046) | 4.08208565 |
| 27 | Dilated cardiomyopathy (HP:0001644) | 4.01597463 |
| 28 | Increased connective tissue (HP:0009025) | 4.00777541 |
| 29 | Asymmetric septal hypertrophy (HP:0001670) | 3.97795338 |
| 30 | Palpitations (HP:0001962) | 3.84042807 |
| 31 | Prolonged QT interval (HP:0001657) | 3.82507181 |
| 32 | Bundle branch block (HP:0011710) | 3.79579086 |
| 33 | Ventricular arrhythmia (HP:0004308) | 3.73438393 |
| 34 | Myotonia (HP:0002486) | 3.67532827 |
| 35 | Calcaneovalgus deformity (HP:0001848) | 3.59385598 |
| 36 | Muscle stiffness (HP:0003552) | 3.31155247 |
| 37 | Heart block (HP:0012722) | 3.27749281 |
| 38 | Absent phalangeal crease (HP:0006109) | 3.18553016 |
| 39 | Ventricular fibrillation (HP:0001663) | 3.17285029 |
| 40 | Deformed tarsal bones (HP:0008119) | 3.16771836 |
| 41 | Atrioventricular block (HP:0001678) | 3.11501637 |
| 42 | Difficulty climbing stairs (HP:0003551) | 3.08881133 |
| 43 | Abnormal atrioventricular conduction (HP:0005150) | 3.08643477 |
| 44 | Distal arthrogryposis (HP:0005684) | 3.00397181 |
| 45 | Neck muscle weakness (HP:0000467) | 2.97760071 |
| 46 | Malignant hyperthermia (HP:0002047) | 2.82845317 |
| 47 | Abnormal EKG (HP:0003115) | 2.77568423 |
| 48 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.75962867 |
| 49 | Areflexia of lower limbs (HP:0002522) | 2.75126267 |
| 50 | Distal lower limb muscle weakness (HP:0009053) | 2.74224978 |
| 51 | Increased variability in muscle fiber diameter (HP:0003557) | 2.73653967 |
| 52 | Round ear (HP:0100830) | 2.71079985 |
| 53 | Myopathic facies (HP:0002058) | 2.67753566 |
| 54 | Left ventricular hypertrophy (HP:0001712) | 2.67261082 |
| 55 | Rimmed vacuoles (HP:0003805) | 2.66311070 |
| 56 | Abnormal finger flexion creases (HP:0006143) | 2.61061301 |
| 57 | Hip contracture (HP:0003273) | 2.58009281 |
| 58 | Fetal akinesia sequence (HP:0001989) | 2.54429391 |
| 59 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.53623674 |
| 60 | Hepatic necrosis (HP:0002605) | 2.52056009 |
| 61 | Acute necrotizing encephalopathy (HP:0006965) | 2.46925146 |
| 62 | Bulbar palsy (HP:0001283) | 2.37367793 |
| 63 | EMG: neuropathic changes (HP:0003445) | 2.35865365 |
| 64 | Ketoacidosis (HP:0001993) | 2.35435666 |
| 65 | Palmoplantar keratoderma (HP:0000982) | 2.34620345 |
| 66 | Generalized muscle weakness (HP:0003324) | 2.34355695 |
| 67 | Weak cry (HP:0001612) | 2.31191121 |
| 68 | Hypoglycemic coma (HP:0001325) | 2.30219744 |
| 69 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.29877305 |
| 70 | Ragged-red muscle fibers (HP:0003200) | 2.25411297 |
| 71 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.22783939 |
| 72 | Ulnar deviation of the wrist (HP:0003049) | 2.22185123 |
| 73 | Limb-girdle muscle atrophy (HP:0003797) | 2.21622746 |
| 74 | Conjunctival hamartoma (HP:0100780) | 2.21523670 |
| 75 | Hypoplastic ischia (HP:0003175) | 2.19043524 |
| 76 | Fatigable weakness (HP:0003473) | 2.17087022 |
| 77 | Abnormality of the neuromuscular junction (HP:0003398) | 2.17087022 |
| 78 | Exercise intolerance (HP:0003546) | 2.14187484 |
| 79 | Hepatocellular necrosis (HP:0001404) | 2.13403050 |
| 80 | Acute encephalopathy (HP:0006846) | 2.11819555 |
| 81 | Muscular dystrophy (HP:0003560) | 2.11083446 |
| 82 | Gowers sign (HP:0003391) | 2.08797292 |
| 83 | Abnormality of the calcaneus (HP:0008364) | 2.07947041 |
| 84 | Increased muscle lipid content (HP:0009058) | 2.07614275 |
| 85 | Progressive macrocephaly (HP:0004481) | 2.03314448 |
| 86 | Popliteal pterygium (HP:0009756) | 2.03119775 |
| 87 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.02600237 |
| 88 | Dicarboxylic aciduria (HP:0003215) | 2.02600237 |
| 89 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.01716077 |
| 90 | Mitochondrial inheritance (HP:0001427) | 2.00381869 |
| 91 | Scapular winging (HP:0003691) | 1.99859806 |
| 92 | Abnormality of the foot musculature (HP:0001436) | 1.98748794 |
| 93 | Cerebral edema (HP:0002181) | 1.97117125 |
| 94 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.96420415 |
| 95 | Increased CSF lactate (HP:0002490) | 1.96030965 |
| 96 | Waddling gait (HP:0002515) | 1.92995008 |
| 97 | Congenital malformation of the right heart (HP:0011723) | 1.91004999 |
| 98 | Double outlet right ventricle (HP:0001719) | 1.91004999 |
| 99 | Abnormality of the ischium (HP:0003174) | 1.90893978 |
| 100 | Facial diplegia (HP:0001349) | 1.90203871 |
| 101 | Pheochromocytoma (HP:0002666) | 1.89356057 |
| 102 | Frequent falls (HP:0002359) | 1.88462281 |
| 103 | Distal lower limb amyotrophy (HP:0008944) | 1.87522573 |
| 104 | Progressive muscle weakness (HP:0003323) | 1.87134615 |
| 105 | Increased intramyocellular lipid droplets (HP:0012240) | 1.86064735 |
| 106 | Sudden cardiac death (HP:0001645) | 1.85417868 |
| 107 | Hyperalaninemia (HP:0003348) | 1.85234151 |
| 108 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.85234151 |
| 109 | Abnormality of alanine metabolism (HP:0010916) | 1.85234151 |
| 110 | Congestive heart failure (HP:0001635) | 1.84333270 |
| 111 | Foot dorsiflexor weakness (HP:0009027) | 1.84295192 |
| 112 | Hypoplastic heart (HP:0001961) | 1.83531305 |
| 113 | Spinal rigidity (HP:0003306) | 1.83341703 |
| 114 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.81463088 |
| 115 | Testicular atrophy (HP:0000029) | 1.81355790 |
| 116 | Lactic acidosis (HP:0003128) | 1.81107149 |
| 117 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.79638228 |
| 118 | Limited hip movement (HP:0008800) | 1.79337851 |
| 119 | Steppage gait (HP:0003376) | 1.78252734 |
| 120 | Slender build (HP:0001533) | 1.77501049 |
| 121 | Proximal amyotrophy (HP:0007126) | 1.77278842 |
| 122 | Aplasia of the musculature (HP:0100854) | 1.76288142 |
| 123 | Lower limb amyotrophy (HP:0007210) | 1.74768576 |
| 124 | Hyperkalemia (HP:0002153) | 1.74472728 |
| 125 | Type 2 muscle fiber atrophy (HP:0003554) | 1.67439278 |
| 126 | Metatarsus adductus (HP:0001840) | 1.62917596 |
| 127 | Limb-girdle muscle weakness (HP:0003325) | 1.54307742 |
| 128 | Muscle fiber atrophy (HP:0100295) | 1.52242200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.74394876 |
| 2 | TTN | 5.64726646 |
| 3 | PHKG2 | 4.31506580 |
| 4 | PHKG1 | 4.31506580 |
| 5 | PDK3 | 3.35107927 |
| 6 | PDK4 | 3.35107927 |
| 7 | MYLK | 3.17055699 |
| 8 | PKN2 | 3.02643538 |
| 9 | DMPK | 2.88165103 |
| 10 | LMTK2 | 2.71418210 |
| 11 | NEK1 | 2.62183842 |
| 12 | STK24 | 2.61874526 |
| 13 | TRIB3 | 2.58565753 |
| 14 | PIK3CA | 2.29941579 |
| 15 | BCKDK | 2.22119360 |
| 16 | MUSK | 2.05917779 |
| 17 | PDK2 | 2.02973001 |
| 18 | PINK1 | 1.90116151 |
| 19 | TIE1 | 1.72990646 |
| 20 | ZAK | 1.43838793 |
| 21 | MAP3K7 | 1.41205916 |
| 22 | ILK | 1.36469215 |
| 23 | MAP2K3 | 1.34773361 |
| 24 | MARK1 | 1.26925691 |
| 25 | NME1 | 1.21238112 |
| 26 | MAPK12 | 1.17875113 |
| 27 | PIK3CG | 1.15167479 |
| 28 | STK38L | 1.14425805 |
| 29 | GRK7 | 1.12641677 |
| 30 | CAMK2D | 1.00904670 |
| 31 | TRPM7 | 1.00773133 |
| 32 | PRKD1 | 0.99000263 |
| 33 | PAK3 | 0.97601288 |
| 34 | CDC42BPA | 0.92617579 |
| 35 | EEF2K | 0.92606912 |
| 36 | FLT3 | 0.89471658 |
| 37 | PRKAA2 | 0.89072915 |
| 38 | PRKAA1 | 0.88890489 |
| 39 | ROCK1 | 0.88451996 |
| 40 | INSRR | 0.78637068 |
| 41 | MAP3K5 | 0.78259191 |
| 42 | MAPKAPK3 | 0.76303604 |
| 43 | STK4 | 0.73449850 |
| 44 | WNK4 | 0.73242258 |
| 45 | MAP3K3 | 0.72617152 |
| 46 | MOS | 0.70728924 |
| 47 | RIPK1 | 0.69407221 |
| 48 | CCNB1 | 0.69197446 |
| 49 | NEK9 | 0.65584962 |
| 50 | DAPK3 | 0.60705583 |
| 51 | PKN1 | 0.58323806 |
| 52 | MAPK4 | 0.58112585 |
| 53 | DYRK1B | 0.56990600 |
| 54 | CAMK4 | 0.54917656 |
| 55 | ERBB3 | 0.52360488 |
| 56 | KSR2 | 0.48924305 |
| 57 | MAP2K1 | 0.48826063 |
| 58 | STK38 | 0.47564658 |
| 59 | CAMK2B | 0.47469012 |
| 60 | KDR | 0.46916271 |
| 61 | MAP2K4 | 0.46735191 |
| 62 | PRKACB | 0.46493940 |
| 63 | AKT2 | 0.46407402 |
| 64 | PDGFRA | 0.46295714 |
| 65 | WNK1 | 0.45485544 |
| 66 | CAMK1 | 0.45025038 |
| 67 | LIMK1 | 0.44581730 |
| 68 | PTK2B | 0.44343064 |
| 69 | CAMK2A | 0.44314646 |
| 70 | ROCK2 | 0.43237701 |
| 71 | TGFBR2 | 0.41584568 |
| 72 | CAMK2G | 0.39876626 |
| 73 | EPHA3 | 0.39176641 |
| 74 | MAP3K10 | 0.38398391 |
| 75 | MAP3K6 | 0.38288167 |
| 76 | STK39 | 0.35213061 |
| 77 | PRKACA | 0.35056926 |
| 78 | PTK6 | 0.34707043 |
| 79 | MAP2K6 | 0.34448387 |
| 80 | DDR2 | 0.34026877 |
| 81 | LATS1 | 0.33563256 |
| 82 | ICK | 0.33210623 |
| 83 | PRKD3 | 0.32788824 |
| 84 | MAP3K13 | 0.32244212 |
| 85 | RPS6KC1 | 0.31811325 |
| 86 | RPS6KL1 | 0.31811325 |
| 87 | PRKACG | 0.30624144 |
| 88 | EPHB1 | 0.29901075 |
| 89 | PDPK1 | 0.28750957 |
| 90 | PDK1 | 0.27492696 |
| 91 | MAPK10 | 0.26134439 |
| 92 | SIK1 | 0.26102385 |
| 93 | MAPK11 | 0.25547682 |
| 94 | RPS6KA6 | 0.24768056 |
| 95 | RPS6KB2 | 0.24602646 |
| 96 | SGK2 | 0.24174137 |
| 97 | PRKG1 | 0.23163796 |
| 98 | LATS2 | 0.21256340 |
| 99 | RPS6KA1 | 0.19034701 |
| 100 | PRKCE | 0.18909818 |
| 101 | MARK2 | 0.15995645 |
| 102 | MTOR | 0.15576142 |
| 103 | MAPK7 | 0.15423739 |
| 104 | SGK1 | 0.15383462 |
| 105 | RPS6KA3 | 0.15363134 |
| 106 | PRKCH | 0.14717061 |
| 107 | NLK | 0.14539127 |
| 108 | RAF1 | 0.14086809 |
| 109 | MAP3K11 | 0.13869876 |
| 110 | LRRK2 | 0.13604007 |
| 111 | STK11 | 0.13592977 |
| 112 | MARK3 | 0.13504251 |
| 113 | SGK3 | 0.12232992 |
| 114 | RET | 0.11955981 |
| 115 | FGFR1 | 0.11936144 |
| 116 | RPS6KB1 | 0.11905742 |
| 117 | MAP3K1 | 0.11470212 |
| 118 | EPHB2 | 0.11286717 |
| 119 | KSR1 | 0.11160290 |
| 120 | PRKG2 | 0.09076413 |
| 121 | PRKCQ | 0.08008516 |
| 122 | STK3 | 0.07056807 |
| 123 | TAOK1 | 0.04694664 |
| 124 | FER | 0.04471696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.00039754 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.46241661 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.31043269 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.95601209 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.84637587 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.15131798 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.06509838 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.99273720 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.81082316 |
| 10 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.75687219 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.71961141 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.61775720 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.20292047 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.16606649 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.05019814 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.02287546 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.84625919 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.84412272 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.82317114 |
| 20 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.63291382 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.60941328 |
| 22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.58802480 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.40465735 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.39166024 |
| 25 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.30794765 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.22607487 |
| 27 | Insulin resistance_Homo sapiens_hsa04931 | 1.22446283 |
| 28 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.15675549 |
| 29 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.09064317 |
| 30 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08116365 |
| 31 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.05090339 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.96419248 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.94912250 |
| 34 | Galactose metabolism_Homo sapiens_hsa00052 | 0.88410035 |
| 35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.86140845 |
| 36 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.83857921 |
| 37 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.82412687 |
| 38 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.80578581 |
| 39 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.80559778 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78667699 |
| 41 | Focal adhesion_Homo sapiens_hsa04510 | 0.78148966 |
| 42 | Tight junction_Homo sapiens_hsa04530 | 0.75091866 |
| 43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.74314158 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.74101334 |
| 45 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.73156365 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.73136741 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72767885 |
| 48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69836806 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.67967736 |
| 50 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.67743027 |
| 51 | Lysine degradation_Homo sapiens_hsa00310 | 0.66206190 |
| 52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65902003 |
| 53 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59289933 |
| 54 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55264747 |
| 55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.54791686 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50384567 |
| 57 | Salivary secretion_Homo sapiens_hsa04970 | 0.49740041 |
| 58 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48064017 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 0.45430301 |
| 60 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43787477 |
| 61 | Adherens junction_Homo sapiens_hsa04520 | 0.43525493 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41155262 |
| 63 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38110587 |
| 64 | Renin secretion_Homo sapiens_hsa04924 | 0.36398270 |
| 65 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.35595160 |
| 66 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.35307807 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34873514 |
| 68 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.32432639 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31349279 |
| 70 | Melanogenesis_Homo sapiens_hsa04916 | 0.30947640 |
| 71 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.28780230 |
| 72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.28654783 |
| 73 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.28615100 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.27753398 |
| 75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.27458007 |
| 76 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.27364089 |
| 77 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.26734129 |
| 78 | Insulin secretion_Homo sapiens_hsa04911 | 0.26690673 |
| 79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.25979428 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.24634304 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24298053 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.23919591 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.22551669 |
| 84 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.20635364 |
| 85 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.20578424 |
| 86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.19726376 |
| 87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.18286129 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.17667452 |
| 89 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.16141917 |
| 90 | GABAergic synapse_Homo sapiens_hsa04727 | 0.14500779 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.14341767 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.13459274 |
| 93 | Circadian entrainment_Homo sapiens_hsa04713 | 0.13268761 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.13067387 |
| 95 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.12562455 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.11958337 |
| 97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.11046452 |
| 98 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.10396700 |
| 99 | Olfactory transduction_Homo sapiens_hsa04740 | 0.10019414 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.08977761 |
| 101 | Bile secretion_Homo sapiens_hsa04976 | 0.03917163 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.02577951 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.01470522 |
| 104 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.00439363 |
| 105 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0622699 |
| 106 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0610086 |
| 107 | Small cell lung cancer_Homo sapiens_hsa05222 | -0.0468116 |
| 108 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.0460766 |
| 109 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | -0.0383525 |
| 110 | Gap junction_Homo sapiens_hsa04540 | -0.0371676 |
| 111 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | -0.0240751 |
| 112 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0173361 |
| 113 | Cholinergic synapse_Homo sapiens_hsa04725 | -0.0163248 |
| 114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | -0.0141864 |
| 115 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0048337 |

